InvestorsHub Logo
Followers 8
Posts 1350
Boards Moderated 0
Alias Born 04/27/2014

Re: None

Tuesday, 11/12/2019 5:05:51 PM

Tuesday, November 12, 2019 5:05:51 PM

Post# of 426487
????? Can someone explain

The briefing documents Tuesday suggest the FDA doesn't support a broad label for Vascepa, SVB Leerink's Fadia said. The advisory committee will also discuss factors such as age, additional risks of cardiovascular disease and LDL cholesterol levels, in addition to triglyceride levels
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News